Retrospective comparison between systematic biopsy versus MRI- with mUS- target biopsy

Retrospective comparison between systematic biopsy versus MRI- with mUS- target biopsy - SYTAB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031562

Enrollment

607

Registered

2025-03-10

Start date

2023-08-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: Systematic biopsy Group 2: Target biopsy (MRT & mUS)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Successful MRI fusion biopsy using micro-ultrasound of the prostate with MRI with PIRADS >= 3

Exclusion criteria

Exclusion criteria: No MRI, no micro-ultrasound

Design outcomes

Primary

Measure	Time frame
Number of clinically significant carcinomas	—

Secondary

Measure	Time frame
Number of clinically non-significant carcinoma	—

Countries

Germany

Contacts

Public ContactMaximilian Reimann

Charité - Universitätsmedizin Berlin, Klinik für Urologie, Campus Benjamin

maximilian.reimann@charite.de+49 30 450 615 249

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026